After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Rigel Pharmaceuticals Inc. (RIGL) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.11, or -9.09%, to $1.1. Volume reached 1,056,163 shares, with price reaching a high of $1.23 and a low of $1.1. Earlier, Yahoo Finance discussed this stock as it revealed Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer.
RIGL belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $1.16 and fluctuated between $1.2080 as its day high and $1.1300 as its day low. The current market capitalization of Rigel Pharmaceuticals Inc. is $213.38M. A total of 3.68 million shares were traded on the day, compared to an average of 4.39M shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, RIGL has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 13 BUYs and 0 SELLs from insiders. Insiders purchased 1,568,750 shares during that period but sold 0.
In the most recent transaction, RODRIGUEZ RAUL R bought 1,000,000 shares of RIGL for 0.69 per share on Jun 09. After the transaction, the CEO, President now owns 1,391,776 company shares.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for RIGL in the last 3 months, the mean price target is $3.92 with high estimates of $15.00 and low estimates of $1.20. In terms of 52-week highs and lows, RIGL has a high of $3.90 and a low of $0.64.
As of this writing, RIGL has an earnings estimate of $-0.13 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $-0.12 per share and a lower estimate of $-0.14. The company reported an EPS of $-0.08 in the last quarter, which was 33.33% higher than expectations of $-0.12.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 7 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RIGL is Overweight with a score of 3.57. A total of 2 analysts rated the stock as Buy while 0 rated it as Overweight while 5 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.